Healthy Clinical Trial
Official title:
Impact of Two Types of Concurrent Training for Optimal Physiological and Physical Benefits in Middle-Aged Adults: a Randomized Controlled Trial
NCT number | NCT05862415 |
Other study ID # | 198511 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 10, 2022 |
Est. completion date | April 10, 2023 |
Verified date | May 2023 |
Source | Princess Nourah Bint Abdulrahman University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
It is widely accepted that aerobic exercise and strengthen training are the core components of most workout programs. However, there is no clear consensus on whether the order in which the exercises are performed impacts their effectiveness. Therefore, the overarching aim of the study is to understand the optimal order of two types of concurrent training program for 13 weeks by comparing the effectiveness of the training on body composition, predicated maximal oxygen uptake (MaxVO2), dynamic respiratory parameters, and muscle strength in healthy middle-aged people. Methods:Thirty-three moderately-active middle-aged and healthy participants were randomly assigned to the strength+aerobic group (SAG, n = 16) and aerobic+strength group (ASG, n = 17). Body composition, aerobic endurance, respiratory parameters and upper and lower strength were assessed before (pre-test) and after (post-test) a 13-week intervention. The chi-square test and the independent t-test will be used to compare sociodemographic variables between the groups. A 2 x 2 analysis of variance (ANOVA) with repeated measures (group x measurement) will be conducted. This study will enhance our understanding of the concurrent training effect on muscle composition and strength. These training programs allow for reducing the duration of the training, which can be an important factor in making adults more willing to participate in physical activity.
Status | Completed |
Enrollment | 33 |
Est. completion date | April 10, 2023 |
Est. primary completion date | February 10, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - middle-aged adults ( over the age of 40) - No history of cardiovascular or neuromuscular disorders - not having orthopedic disorder or neurologic disorders. Exclusion Criteria: - adults using artificial prosthesis - participation in any structured training program - any disease that precludes exercise or necessitates special care (for example, coronary artery disease, thrombosis, moderate or severe bone disease, and lung or renal disease) |
Country | Name | City | State |
---|---|---|---|
Saudi Arabia | Princess Nourah bint Abdulrahman University | Riyadh |
Lead Sponsor | Collaborator |
---|---|
Monira Aldhahi |
Saudi Arabia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body fat % | To measure the BF%, a bioelectrical impedance analysis was used. The participants will be instructed to stand barefoot on the bioelectrical impedance analysis devices (seca mBCA 515, Hamburg, Germany).The device measures the body composition and includes a platform with handrails and electrodes that measure the impedance passed through the pairs of hands and feet while standing. Impedance was measured over 75 s with a current of 100 µA at a frequency range between 1 kHz and 1000 kHz and a capacity of 360 kg. Waist circumference measurement at the umbilicus and level physical activity level were inputted to indirectly estimate the body composition. | 10 min | |
Primary | Predicated maximal oxygen uptake (MaxVO2) | 1-mile walk-run performance test was used. The aim of this test is to cover a distance of one mile in the shortest possible time. Participants can alternate between walking and running as desired; however, they should be encouraged to cover the distance as quickly as feasible. The time elapsed to cover a mile distance, measured in minutes and seconds. During the testing and recovery the heart rate of the participants was monitored with a heart rate sensor (Polar Verity Sense; Kempele, Finland). Polar Verity Sense can be connected to a sports watch or app via Bluetooth®, ANT+, and internal memory to instantly track your training or view the data after training. As a result, the participant's time for completing the 1-mile test was tracked using a smart phone GPS system. The validity of the device has previously been reported previously[27]. The participants' MaxVO2 values were calculated using the formulas below. | 1 day | |
Primary | Forced Vital Capacity (FVC) | a spirometer device (Minispir®, PC-based Spirometer with Oximetry option, Italy) will be used to measure the Forced Vital Capacity (FVC), Forced Expiratory Volume in One Second (FEV1). | 1 day | |
Primary | Forced Expiratory Volume in One Second | a spirometer device (Minispir®, PC-based Spirometer with Oximetry option, Italy) will be used to measure the Forced Vital Capacity (FVC), Forced Expiratory Volume in One Second (FEV1). | 1 day | |
Primary | Grip Strength | A handgrip dynamometer was used to measure the strength of the hand and forearm muscles (in kilograms) (Tanita Handgrip Meter, RM40, East Malaysia). The test was carried out with the elbow fully extended and the forearm in a neutral position. At 1-minute intervals, three measurements were taken on the subjects' dominant side. The participants were instructed to told the handgrip of the device tightly for 3 seconds[30]. For statistical analysis, the highest scores from three measurements were taken. | 1 day | |
Primary | 1-Repetition Maximum Strength | The indirect 1 repetition maximum (1RM) test is relatively simple, efficient, and safe when used and administered. The maximum repetition between 2 and 20 for any weight can be used to indirectly compute the 1RM value using the calculations. The formulas for calculating 1RM allow for weightlifting repetitions of less than 20 and a linear or curved relationship between the percentages of 1RMI. In order to determine the 1RM values of the study participants, indirect 1RM bench press, leg press, long pulley, leg extension, and overhead press were used. 1RM tests were performed using a weight machine (Technogym Selection 900). | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |